[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Arcutis Biotherapeutics, Inc. Common Stock (ARQT)

Arcutis Biotherapeutics' stock surges to a 52-week high, fueled by strong Q3 earnings and anticipation of an FDA decision. Social media buzz highlights positive sentiment and analyst upgrades.

### About Arcutis Biotherapeutics, Inc. Common Stock
Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for dermatological conditions.  
Arcutis Biotherapeutics, Inc. Common Stock uses the ticker $ARQT for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Arcutis Biotherapeutics, Inc. Common Stock (ARQT) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Arcutis Biotherapeutics, Inc. Common Stock (ARQT) market dominance near a 52-week low at XXXXXXX.
- Arcutis Biotherapeutics, Inc. Common Stock (ARQT) trading volume is up XXXXXX% from the previous X months.
- Arcutis Biotherapeutics, Inc. Common Stock (ARQT) social dominance is up XXXXXX% from the previous X months.
- Arcutis Biotherapeutics, Inc. Common Stock (ARQT) posts created is up XXXXX% from the previous week.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/close.tsv)  
The stock price has surged to a 52-week high, supported by strong Q3 earnings, positive revenue growth, and anticipation of an FDA decision. High social media engagement and positive sentiment further bolster this upward trend.  

24-Hour: -XXXX%
7-Day: XXXX%
30-Day: XXXXX%

1-Year High: $XXXXX on 2025-12-05  
1-Year Low: $XXXXX on 2025-02-11  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/alt_rank.tsv)  
Arcutis Biotherapeutics, Inc. Common Stock (ARQT) is currently AltRank #975 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX +88  
X Month: XXX +184  
1-Year High: XXXXX on 2025-11-07  
1-Year Low: XXX on 2025-11-23  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -X  
X Month: XX -XX  
1-Year High: XX on 2025-11-09  
1-Year Low: XX on 2025-11-25  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX +10%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXX -XXXX%  
1-Year High: XXXXXXX on 2025-02-21  
1-Year Low: XXX on 2025-09-21  

Engagements by network (24h):
X: XXXXX
YouTube: X

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XXXX%  
X Month: XXX +21%  
X Months: XXXXX +67%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2025-06-28  
1-Year Low: XX on 2025-09-14  

Mentions by network (24h):
X: XXX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Arcutis Biotherapeutics, Inc. Common Stock (ARQT) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX +9.20%  
X Month: XXX +9.90%  
X Months: XXXXX +180%  
X Year: XXXXX +148%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-09-21  

The most influential creators that mention Arcutis Biotherapeutics, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | X    | XXXXXX    | X     | XXX         |
| [@RebellioMarket](/creator/twitter/RebellioMarket)   | X    | XXXXXXX   | X     | XXX         |
| [@equitydd](/creator/twitter/equitydd)               | X    | XXXXX     | X     | XXX         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XXX         |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXX         |
| [@TedHZhang](/creator/twitter/TedHZhang)             | X    | XXXXXX    | X     | XX          |
| [@DeepSouthDoctor](/creator/twitter/DeepSouthDoctor) | X    | XXXXX     | X     | XX          |
| [@SteveDJacobs](/creator/twitter/SteveDJacobs)       | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$arqt/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% +20%  
X Year: XXX% no change  
1-Year High: XXX% on 2025-01-31  
1-Year Low: XX% on 2025-09-23  

Most Supportive Themes:
- Positive Q3 Earnings and Revenue: (30%) Arcutis Biotherapeutics reported a profitable third quarter with revenue significantly exceeding expectations, driven by strong Zoryve sales.
- FDA Decision Catalyst: (25%) An upcoming FDA decision for a topical foam treatment for psoriasis is viewed as a significant catalyst for the company.
- Analyst Upgrades and Price Target Increases: (20%) Multiple analysts have raised their price targets for ARQT, with Goldman Sachs maintaining a Neutral rating and Mizuho raising their target significantly.
  
Most Critical Themes:
- Neutral Analyst Rating: (15%) Despite positive Q3 results and revenue growth, Goldman Sachs maintains a 'Neutral' rating, suggesting a balanced outlook from this key analyst.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.0031%  
X Month: XXXXX% +0.02%  
X Months: XXXXX% +0.021%  
X Year: XXXXX% +0.013%  
1-Year High: XXXXX% on 2024-12-26  
1-Year Low: XXXXXX% on 2025-09-14  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-11-24  
1-Year Low: XXXXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$1.30%  
X Month: $XXXXXXXXXXXXX +$23%  
1-Year High: $XXXXXXXXXXXXX on 2025-12-05  
1-Year Low: $XXXXXXXXXXXXX on 2025-10-27  

### Top Arcutis Biotherapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Lots of buyout favorites dropping $BBIO $MDGL $ARQT $CYTK One is rising $ABVX"  
[X Link](https://x.com/SnackBioTech/status/1998485018063286450) [@SnackBioTech](/creator/x/SnackBioTech) 2025-12-09T20:08Z 2069 followers, 1882 engagements


"$opal $arqt $crvs $ivvd Small caps with momo"  
[X Link](https://x.com/STvrosb/status/1998420275596284312) [@STvrosb](/creator/x/STvrosb) 2025-12-09T15:51Z XXX followers, XXX engagements


"I nibbled some of $MIRM $ARQT $TVTX $LQDA $IMNM and $NAMS. That should get me back to my 50/50 weight of stocks and cash for $XBI $XXX. Now I can sell more stocks at higher price later as the FOMO goes to $130"  
[X Link](https://x.com/Biotech2k1/status/1998414312717836651) [@Biotech2k1](/creator/x/Biotech2k1) 2025-12-09T15:27Z 33.1K followers, 1943 engagements


"#NEWS: Were pleased to welcome Amit Munshi to our Board of Directors bringing deep expertise and visionary leadership to Arcutis. We also thank Bhaskar Chaudhuri for many years of significant contributions dedication and insights. Read more:"  
[X Link](https://x.com/ArcutisBio/status/1998141721306177975) [@ArcutisBio](/creator/x/ArcutisBio) 2025-12-08T21:24Z XXX followers, XX engagements